Supply chain transparency needed to combat soaring insulin costs
Thursday, November 1, 2018 - 16:20
in Health & Medicine
Spiraling insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. The Endocrine Society is calling on stakeholders across the supply chain to help reduce out-of-pocket costs for people with diabetes.